Exscientia · pitchdeck
Exscientia | IPO Presentation Deck | 60 slides
60 pages · 3 arc beats · 2 loops
Exscientia | IPO Presentation Deck | 60 slides
Exscientia · 2021-09 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
124681012141618202224262830323436384042444648505254565860
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 63 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits — 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides · 2 hits Solution 57 slides 100% 57/57 slides 100% 57/57 slides · 280 hits — 0/57 slides
56.1% 32/57 slides · 38 hits 50.9% 29/57 slides 100% 57/57 slides · 63 hits 100% 57/57 slides · 61 hits Competition 5 slides 100% 5/5 slides 100% 5/5 slides · 28 hits — 0/5 slides
80% 4/5 slides 60% 3/5 slides 100% 5/5 slides · 10 hits 100% 5/5 slides Slide inventory
60 every slide · same image gating as the playbook
01
The graphic is a stylized tree structure resembling a chemical molecular structure.front_matter
04
The slide uses a horizontal flow diagram to connect three core pillars of the business.summarize
05
The slide uses a visual flow/network graphic to connect the three achievements.show_traction
06
The slide uses a matrix-like structure to map partners against project milestones.show_traction
08
The chart illustrates a shift in the economic lifecycle curve of drug development.present_solution
09
The slide uses a combination of stacked bar charts and a side-by-side bar chart to demonstrate efficiency gains.compare_peers
10
Uses a histogram to visualize the distribution of rNPV outcomes across different scenarios, highlighting a 593% increase in the best-case scenario.analyze_data
11
The chart uses a stacked area representation to show the growth of different project types over time, aligned with four distinct operational phases.plan_implementation
12
The slide uses a timeline-like structure to show drug development stages from Early Discovery to Clinical, with a separate box for DaaS (Drug-as-a-Service) prodshow_traction
13
The visual uses a network/wave motif to connect the three pillars of their AI approach.present_solution
14
The diagram uses a circular, iterative flow (flywheel-like) to represent the 'learning process' of the AI architecture.present_solution
15
The slide uses a process-flow visual to represent four distinct technical capabilities.present_solution
16
The slide outlines a proprietary laboratory and software workflow.present_solution
17
The slide uses a process flow to demonstrate the efficacy of a drug testing platform.present_solution
18
Includes Kaplan-Meier survival curves and hazard ratios (HR) from a study published in The Lancet Haematology.show_traction
19
The heatmap uses hierarchical clustering to group patient samples and drug responses.present_solution
20
The slide uses a process flow diagram showing the transition from Target Product Profile (table) to MPO (code snippet) to Merit (scatter plot).present_solution
21
The diagram uses a hub-and-spoke style flow to represent the integration of multiple data types and AI models into a unified generative design platform.present_solution
22
The slide is entirely white with a circular vignette effect and a page number '22' in the bottom right corner.filler
23
The slide contains only a 3D rendering of a protein molecule against a black background, with the company logo in the bottom left corner.filler
24
The chart shows a Pareto-like frontier of compounds, with specific points highlighted as 'selected by active learning' that are not necessarily on the immediatepresent_solution
25
The visual is a node-link diagram representing complex data relationships, likely protein-ligand interactions or chemical space mapping.illustrate_case
26
Includes a biological pathway diagram and a honeycomb diagram representing cancer indications.present_solution
27
The slide uses a three-column structure to define the target product profile (TPP) for a drug candidate.present_solution
28
The table uses a traffic-light color coding system (green/yellow/red) to indicate performance against criteria.compare_peers
29
The table uses a color-coded system (green, yellow, red) to indicate performance relative to candidate criteria.compare_peers
30
The charts show dose-dependent tumor regression in mouse models.show_traction
31
The slide uses a series of small-multiple line charts to demonstrate dose-response curves across different time points (24h, 48h, 72h).compare_peers
32
The slide uses a small multiples approach to show individual patient responses across three different experiments (EXP403, EXP617, EXP665) and three time pointsanalyze_data
34
This is a standard corporate footer/contact slide often found at the end of a pitch deck.other
35
The visualization appears to be a node-link diagram representing a network or cluster structure.appendix
36
Uses a visual flow to represent the drug discovery process bottlenecks.frame_problem
37
The network graph likely represents drug discovery pathways or viral transmission modeling.establish_context
38
The slide uses a comparative structure to detail the characteristics and impact of three major viral families.frame_problem
40
The visual is a network graph showing interconnected nodes, likely representing chemical or biological data clusters.illustrate_case
41
The table uses a color-coded system (green, yellow, red) to indicate how well each candidate meets predefined criteria.compare_peers
42
The slide uses a process-flow layout to show the progression from experiment to AI-driven design to final compound.illustrate_case
43
The chart displays tumor growth inhibition over time, comparing a control (isotype + vehicle) against the drug candidate and a positive control (anti-PD-1).show_traction
44
The slide uses three line charts to demonstrate dose-response curves for three different compounds.compare_peers
45
The slide presents two sets of box plots comparing DMSO control vs 25uM treatment across different cancer types and time points.show_traction
46
The slide uses a network graph visualization to represent complex data relationships.illustrate_case
47
The slide uses a traffic-light color coding system (green/yellow/red) to visualize performance across various biochemical and cellular assays.compare_peers
48
The slide uses a process flow diagram to illustrate the integration of wet-lab experimentation and AI-driven design.present_solution
49
The visual is a node-link diagram representing complex data relationships.illustrate_case
50
The slide uses a color-coded heatmap to demonstrate superiority of proprietary compounds over a competitor.compare_peers
52
The visual is a node-link diagram representing a complex network, likely illustrating drug discovery pathways or molecular interactions.appendix
53
The central icon represents the patient-centric focus, surrounded by four operational pillars.present_solution
54
The diagram illustrates a 'human-in-the-loop' design process combined with automated generative optimization.present_solution
55
The background image is an abstract, textured surface, likely intended to evoke complexity or a landscape of data points.inspire_vision
56
The central diagram is a classic flywheel representation.present_solution
57
The image shows a molecular binding site visualization with a legend for Apolar, Acceptor, and Donor regions.present_solution
58
The diagram illustrates a data pipeline from raw image data to feature engineering, aggregation, and finally generative design.present_solution
59
The slide highlights three specific bispecific programs as proof points for their platform's efficacy.present_solution
60
This is a standard corporate disclosure/contact slide often found at the end of a pitch deck.front_matter